Zhejiang Xinguang Pharmaceutical Co Ltd (300519) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.006x

Based on the latest financial reports, Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has a cash flow conversion efficiency ratio of -0.006x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-5.00 Million ≈ $-731.38K USD) by net assets (CN¥814.66 Million ≈ $119.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Zhejiang Xinguang Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.

Zhejiang Xinguang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Zhejiang Xinguang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Xinguang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Xinguang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Australian Clinical Labs Ltd AU:ACL	0.416x
Siddhi Acquisition Corp Class A Common stock NASDAQ:SDHI	-0.001x
Q Capital Partners Co. Ltd KQ:016600	-0.015x
Anton Oilfield Services Group F:5AO	0.045x
Prataap Snacks Limited NSE:DIAMONDYD	0.038x
DYNAGREEN EN.PR.GR.H YC 1 F:DYN	0.037x
Opus Genetics, Inc. NASDAQ:IRD	-0.641x
Invesco Municipal Income Opportunities Closed Fund Class Common NYSE:OIA	0.021x

Annual Cash Flow Conversion Efficiency for Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Zhejiang Xinguang Pharmaceutical Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥830.53 Million ≈ $121.53 Million	CN¥53.43 Million ≈ $7.82 Million	0.064x	+1.91%
2023-12-31	CN¥844.12 Million ≈ $123.52 Million	CN¥53.29 Million ≈ $7.80 Million	0.063x	-57.11%
2022-12-31	CN¥858.89 Million ≈ $125.68 Million	CN¥126.43 Million ≈ $18.50 Million	0.147x	-12.50%
2021-12-31	CN¥846.22 Million ≈ $123.83 Million	CN¥142.36 Million ≈ $20.83 Million	0.168x	+23.53%
2020-12-31	CN¥826.94 Million ≈ $121.01 Million	CN¥112.61 Million ≈ $16.48 Million	0.136x	+10.82%
2019-12-31	CN¥799.71 Million ≈ $117.02 Million	CN¥98.27 Million ≈ $14.38 Million	0.123x	-0.23%
2018-12-31	CN¥753.26 Million ≈ $110.23 Million	CN¥92.77 Million ≈ $13.58 Million	0.123x	-30.03%
2017-12-31	CN¥705.81 Million ≈ $103.28 Million	CN¥124.23 Million ≈ $18.18 Million	0.176x	-6.98%
2016-12-31	CN¥640.46 Million ≈ $93.72 Million	CN¥121.18 Million ≈ $17.73 Million	0.189x	-53.11%
2015-12-31	CN¥309.35 Million ≈ $45.27 Million	CN¥124.84 Million ≈ $18.27 Million	0.404x	+0.67%
2014-12-31	CN¥249.00 Million ≈ $36.44 Million	CN¥99.82 Million ≈ $14.61 Million	0.401x	+40.78%
2013-12-31	CN¥201.97 Million ≈ $29.55 Million	CN¥57.51 Million ≈ $8.42 Million	0.285x	-25.23%
2012-12-31	CN¥141.62 Million ≈ $20.72 Million	CN¥53.93 Million ≈ $7.89 Million	0.381x	+15.50%
2011-12-31	CN¥104.32 Million ≈ $15.27 Million	CN¥34.40 Million ≈ $5.03 Million	0.330x	--

About Zhejiang Xinguang Pharmaceutical Co Ltd

SHE:300519 China Drug Manufacturers - Specialty & Generic

Market Cap

$290.79 Million

CN¥1.99 Billion CNY

Market Cap Rank

#15076 Global

#4460 in China

Share Price

CN¥12.42

Change (1 day)

-1.27%

52-Week Range

CN¥12.42 - CN¥20.05

All Time High

CN¥52.02